PCM
BIOX icon

Prelude Capital Management’s Bioceres Crop Solutions BIOX Stock Holding History

Prelude Capital Management’s Portfolio BIOX Stock Details BIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-20,968
Closed -$237K – 1140
2023
Q3 		$237K Sell
20,968
-3,663
-15% -$43.9K 0.02% 804
2023
Q2 		$329K Sell
24,631
-10,173
-29% -$119K 0.02% 601
2023
Q1 		$404K Buy
34,804
+8,582
+33% +$101K 0.02% 530
2022
Q4 		$315K Buy
+26,222
New +$340K 0.02% 780

Other funds holding BIOX

SP
Solel Partners Boston, Massachusetts $468M AUM 2.45% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
FSC
Fourth Sail Capital Camana Bay Grand Cayman, Cayman Islands $608M AUM 48.69% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
BAM
Ballast Asset Management Dallas, Texas $225M AUM 38.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Prelude Capital Management's BIOX Position: Q4 2023 in Review

Prelude Capital Management sold out of Bioceres Crop Solutions (BIOX) in Q4 2023, closing a stake of 20,968 shares — an estimated $237K sold.

Prelude Capital Management first reported a position in BIOX in Q4 2022 and held it in 4 quarters. The position peaked at $404K in Q1 2023. 51 funds tracked by Wall St. Rank hold BIOX as of Q4 2023.

  • Prelude Capital Management reported no remaining Bioceres Crop Solutions position as of Q4 2023 after selling out during the quarter.
  • Prelude Capital Management sold 20,968 Bioceres Crop Solutions shares in Q4 2023, an estimated $237K.
  • Prelude Capital Management first reported a position in Bioceres Crop Solutions in Q4 2022 and held it in 4 quarters.
  • Prelude Capital Management's Bioceres Crop Solutions position peaked at $404K in Q1 2023.
  • 51 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q4 2023.

Based on Prelude Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.